Study of Patient With Frequent Exacerbations in Moscow
← catalyst calendarNCT07307781 · readout in 310 d
Sponsored by AstraZeneca (industry) · AZN — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
500estimated
Sites
1
Country
Russia
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-11-28 | actual | When the study began enrolling |
| Primary completion | 2027-06-25 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2027-06-25 | estimated | The whole study's end, after follow-up |
| First posted | 2025-12-29 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-05-29 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Chronic Obstructive Pulmonary Disease (COPD)
Primary outcomes
what the primary-completion date above is the date OFTo describe the baseline mean age of outpatients with COPD in Moscow.
measured 52 weeks of retrospective data before visit 1
To describe the baseline Demographic data characterisics of outpatients with COPD in Moscow.
measured 52 weeks of retrospective data before visit 1
To describe the baseline Negative lifestyle factors of outpatients with COPD in Moscow.
measured 52 weeks of retrospective data before visit 1
To describe the baseline Anthropometry data characterisics of outpatients with COPD in Moscow.
measured 52 weeks of retrospective data before visit 1
To describe the baseline mean smoking index .
measured 52 weeks of retrospective data before visit 1
To describe the baseline mean duration of smoking
measured 52 weeks of retrospective data before visit 1
To describe a COPD clinical course of outpatients with COPD in Moscow
measured 52 weeks of retrospective data before visit 1
To describe a COPD exacerbation of outpatients with COPD in Moscow
measured 52 weeks of retrospective data before visit 1
To describe a severe COPD exacerbation of outpatients with COPD in Moscow
measured 52 weeks of retrospective data before visit 1
To describe a COPD drug therapy of outpatients with COPD in Moscow
measured 52 weeks of retrospective data before visit 1
To describe a Spirometry parameters at baseline of outpatients with COPD in Moscow
measured 52 weeks of retrospective data before visit 1
To describe a FEV1 / FVC ratio at baseline of outpatients with COPD in Moscow
measured 52 weeks of retrospective data before visit 1
To describe Blood eosinophils count at baseline of outpatients with COPD in Moscow
measured 52 weeks of retrospective data before visit 1
To describe CAT questionnaire score at baseline of outpatients with COPD in Moscow
measured 52 weeks of retrospective data before visit 1
To describe Healthcare resource utilization of outpatients with COPD in Moscow
measured 52 weeks of retrospective data before visit 1
To describe COPD comorbidities at baseline of outpatients with COPD in Moscow
measured 52 weeks of retrospective data before visit 1
To describe COPD and Heart Failure comorbidity at baseline of outpatients with COPD in Moscow
measured 52 weeks of retrospective data before visit 1
To describe LVEF at baseline of outpatients with COPD in Moscow
measured 52 weeks of retrospective data before visit 1
To describe COPD and Chronic Kidney Disease comorbidity at baseline of outpatients with COPD in Moscow
measured 52 weeks of retrospective data before visit 1
To describe COPD and Arterial Hypertension (AH) comorbidity at baseline of outpatients with COPD in Moscow
measured 52 weeks of retrospective data before visit 1
To describe blood pressure at baseline of outpatients with COPD in Moscow
measured at visit 1
To describe a treatment of comorbidities at baseline of outpatients with COPD in Moscow
measured at visit 1
Permalink · AZN's whole pipeline · Catalyst calendar · Every registered study · What changed